Table 1.
African-American
|
Non-Hispanic white
|
Hispanic
|
||||
---|---|---|---|---|---|---|
Cases (n = 168) |
Controls (n = 269) |
Cases (n = 233) |
Controls (n = 245) |
Cases (n = 116) |
Controls (n = 130) |
|
Age, mean±SD | 22.3±12.7 | 32.5±11.3 | 23.9±13.1 | 32.7±11.0 | 17.4±11.7 | 36.8±12.3 |
% Male | 45.8 | 44.6 | 39.5 | 39.8 | 46.5 | 32.3 |
IgE, IU/mL (geo. mean) | 204.2±4.1 | 66.1±4.4 | 138.0±4.6 | 15.5±6.8 | 223.9±4.7 | 32.4±4.9 |
FEV1, % predicted (SD)* | 75.5 (20.6) | ND | 82.6 (16.4) | ND | 95.2 (15.9) | ND |
Mean FEV1/FVC | 0.7±0.1 | ND | 0.8±0.1 | ND | 0.8±0.1 | ND |
Mean PC20, mg/mL | 3.5±5.1 | ND | 3.6±5.8 | ND | 3.9±5.9 | ND |
Percent predicted FEV1 values for African-Americans are race-adjusted [14].
ND, not determined.